Drug Shortage Report for DEXAMETHASONE

Last updated on 2023-07-07 History
Report ID 184454
Drug Identification Number 02023865
Brand name DEXAMETHASONE
Common or Proper name Dexamethasone
Company Name PHARMA STULLN INC.
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE SODIUM PHOSPHATE
Strength(s) 0.1%
Dosage form(s) SOLUTION SOLUTION
Route of administration OTIC OPHTHALMIC OTIC OPHTHALMIC
Packaging size Dexamethasone 0.1% 5ml bottle
ATC code S03BA
ATC description CORTICOSTEROIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-02-13
Actual start date 2023-02-13
Estimated end date 2023-05-30
Actual end date 2023-07-06
Shortage status Resolved
Updated date 2023-07-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6500 TRANS CANADA HIGHWAY, SUITE 400
POINTE-CLAIRE, QUEBEC
CANADA H9R 0A5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-07-07 French Compare
v11 2023-07-07 English Compare
v10 2023-05-17 French Compare
v9 2023-05-17 English Compare
v8 2023-05-17 French Compare
v7 2023-05-17 English Compare
v6 2023-04-03 French Compare
v5 2023-04-03 English Compare
v4 2023-02-14 English Compare
v3 2023-02-13 French Compare
v2 2023-02-13 French Compare
v1 2023-02-13 English Compare

Showing 1 to 12 of 12